Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Junji Furuse et al.|The Lancet|2023Cited by 1k
The effect of long-term low-dose lead exposure on thyroid function in adolescentsBumin Nuri Dündar, İnci İLHAN, Meltem Koyuncu Arslan et al.|Environmental Research|2006Cited by 83